{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:55:13Z","timestamp":1793890513737,"version":"4.8.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jaci.2014.12.1932","type":"journal-article","created":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T00:34:29Z","timestamp":1423528469000},"page":"946-955.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":172,"title":["Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis"],"prefix":"10.1016","volume":"135","author":[{"given":"Katherine G.","family":"MacDonald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.J.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James V.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan K.","family":"Levings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raewyn","family":"Broady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2014.12.1932_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","article-title":"Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities","volume":"8","author":"Bhattacharyya","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib2","first-page":"172","article-title":"Systemic sclerosis: a critical digest of the recent literature","volume":"31","author":"Tani","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1684\/ecn.2013.0325","article-title":"T cell abnormalities in systemic sclerosis with a focus on Th17 cells","volume":"23","author":"Brembilla","year":"2012","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.jaci.2014.12.1932_bib4","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/rheumatology\/kes090","article-title":"T cells in systemic sclerosis: a reappraisal","volume":"51","author":"O'Reilly","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaci.2014.12.1932_bib5","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1002\/art.22927","article-title":"Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis","volume":"56","author":"Parel","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2014.12.1932_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/art.10049","article-title":"Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens","volume":"46","author":"Scaletti","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2014.12.1932_bib7","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archderm.1996.03890310088013","article-title":"Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis","volume":"132","author":"Salmon-Ehr","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib8","first-page":"1751","article-title":"Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis","volume":"151","author":"Mavalia","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2005-11-4567","article-title":"TNF downmodulates the function of human CD4+CD25hi T-regulatory cells","volume":"108","author":"Valencia","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2014.12.1932_bib10","doi-asserted-by":"crossref","first-page":"e5903","DOI":"10.1371\/journal.pone.0005903","article-title":"The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2014.12.1932_bib11","first-page":"765","article-title":"Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis","volume":"27","author":"Meloni","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib12","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar3486","article-title":"Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease","volume":"13","author":"Truchetet","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaci.2014.12.1932_bib13","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s00296-011-2056-y","article-title":"Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study","volume":"32","author":"Rodriguez-Reyna","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaci.2014.12.1932_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3109\/08830185.2013.811657","article-title":"The role of FOXP3 in regulating immune responses","volume":"33","author":"Vent-Schmidt","year":"2014","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib16","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1365-2133.2010.09633.x","article-title":"Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea","volume":"162","author":"Antiga","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib17","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/annrheumdis-2011-200709","article-title":"Activated\u00a0and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions","volume":"71","author":"Mathian","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2014.12.1932_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cellimm.2009.12.009","article-title":"Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity","volume":"261","author":"Slobodin","year":"2010","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib19","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/annrheumdis-2012-202216","article-title":"Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus","volume":"72","author":"Alexander","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2014.12.1932_bib20","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/ard.2009.116525","article-title":"Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma","volume":"70","author":"Klein","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2014.12.1932_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nri3605","article-title":"Homeostatic control of regulatory T cell diversity","volume":"14","author":"Liston","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib22","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.4049\/jimmunol.1003099","article-title":"Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes","volume":"186","author":"McClymont","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.smim.2013.10.009","article-title":"The plasticity of human Treg and Th17 cells and its role in autoimmunity","volume":"25","author":"Kleinewietfeld","year":"2013","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib24","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1182\/blood-2012-08-443473","article-title":"CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines","volume":"121","author":"Pesenacker","year":"2013","journal-title":"Blood"},{"issue":"suppl","key":"10.1016\/j.jaci.2014.12.1932_bib25","first-page":"S42","article-title":"Assessment of disease severity and prognosis","volume":"21","author":"Medsger","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib26","first-page":"2159","article-title":"A disease severity scale for systemic sclerosis: development and testing","volume":"26","author":"Medsger","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib27","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.jid.5700199","article-title":"A novel method for the isolation of skin resident T cells from normal and diseased human skin","volume":"126","author":"Clark","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib28","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1182\/blood-2010-07-295436","article-title":"Cutaneous GVHD is associated with the expansion of tissue-localized Th1 and not Th17 cells","volume":"116","author":"Broady","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2014.12.1932_bib29","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1084\/jem.193.11.1295","article-title":"Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in\u00a0vitro without loss of function","volume":"193","author":"Levings","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2014.12.1932_bib30","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood-2006-02-002873","article-title":"IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin","volume":"109","author":"Clark","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2014.12.1932_bib31","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1172\/JCI72932","article-title":"Memory regulatory T cells reside in human skin","volume":"124","author":"Sanchez Rodriguez","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2014.12.1932_bib32","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar4430","article-title":"Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction","volume":"16","author":"Yang","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaci.2014.12.1932_bib33","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1182\/blood-2012-05-431023","article-title":"A novel function for FOXP3 in humans: intrinsic regulation of conventional T cells","volume":"121","author":"McMurchy","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2014.12.1932_bib34","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#","article-title":"CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease","volume":"30","author":"Cosmi","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib35","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ni.f.214","article-title":"Chemokines and leukocyte traffic","volume":"9","author":"Sallusto","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/intimm\/dxm014","article-title":"Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production","volume":"19","author":"Allan","year":"2007","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib37","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1182\/blood-2011-11-392324","article-title":"Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells","volume":"119","author":"Duhen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2014.12.1932_bib38","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.4049\/jimmunol.162.3.1278","article-title":"Selective expression of a novel surface molecule by human Th2 cells in\u00a0vivo","volume":"162","author":"Nagata","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib39","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/40166","article-title":"Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells","volume":"389","author":"Fuhlbrigge","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2014.12.1932_bib40","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nm.2389","article-title":"Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease","volume":"17","author":"Dominguez-Villar","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2014.12.1932_bib41","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2014.12.1932_bib42","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1182\/blood-2008-10-183251","article-title":"IL-17-producing human peripheral regulatory T cells retain suppressive function","volume":"113","author":"Beriou","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2014.12.1932_bib43","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/1523-1747.ep12560826","article-title":"Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization","volume":"90","author":"Kahari","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2362.1988.tb01158.x","article-title":"Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization","volume":"18","author":"Scharffetter","year":"1988","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaci.2014.12.1932_bib45","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s10753-014-9848-7","article-title":"Association\u00a0of\u00a0interleukin 1 family with systemic sclerosis","volume":"37","author":"Zhang","year":"2014","journal-title":"Inflammation"},{"key":"10.1016\/j.jaci.2014.12.1932_bib46","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10067-011-1686-5","article-title":"Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis","volume":"30","author":"Yanaba","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib47","first-page":"144","article-title":"Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis","volume":"72","author":"Terras","year":"2013","journal-title":"Ann\u00a0Rheum Dis"},{"key":"10.1016\/j.jaci.2014.12.1932_bib48","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10875-014-0037-0","article-title":"Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels","volume":"34","author":"Vettori","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib49","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/ard.2009.119321","article-title":"The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis","volume":"69","author":"Manetti","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2014.12.1932_bib50","doi-asserted-by":"crossref","first-page":"587376","DOI":"10.1155\/2014\/587376","article-title":"Role of IL-33 and its receptor in T cell-mediated autoimmune diseases","volume":"2014","author":"Zhao","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jaci.2014.12.1932_bib51","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2013.10.054","article-title":"A\u00a0special population of regulatory T cells potentiates muscle repair","volume":"155","author":"Burzyn","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2014.12.1932_bib52","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature13577","article-title":"The alarmin IL-33 promotes regulatory T-cell function in the intestine","volume":"513","author":"Schiering","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2014.12.1932_bib53","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2014.12.1932_bib54","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.it.2012.01.002","article-title":"Regulatory T cell migration during an immune response","volume":"33","author":"Ding","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib55","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1084\/jem.20072594","article-title":"Foxp3+ regulatory T\u00a0cells\u00a0maintain immune homeostasis in the skin","volume":"205","author":"Dudda","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2014.12.1932_bib56","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1172\/JCI35834","article-title":"The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous\u00a0antigen-specific memory response in\u00a0vivo","volume":"118","author":"Vukmanovic-Stejic","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2014.12.1932_bib57","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/sj.mt.6300341","article-title":"Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3","volume":"16","author":"Allan","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaci.2014.12.1932_bib58","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1371\/journal.pbio.0050329","article-title":"GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells","volume":"5","author":"Mantel","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib59","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature07674","article-title":"Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses","volume":"458","author":"Zheng","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2014.12.1932_bib60","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.4049\/jimmunol.1001255","article-title":"An intrinsic mechanism predisposes Foxp3-expressing regulatory T cells to Th2 conversion in\u00a0vivo","volume":"185","author":"Wang","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib61","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/nm.2896","article-title":"Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma","volume":"18","author":"Krishnamoorthy","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2014.12.1932_bib62","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.immuni.2012.03.018","article-title":"Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells","volume":"36","author":"Seneschal","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2014.12.1932_bib63","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.4049\/jimmunol.0903306","article-title":"IL-33 induces IL-13-dependent cutaneous fibrosis","volume":"184","author":"Rankin","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1932_bib64","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.4049\/jimmunol.1400481","article-title":"IL-33 is an unconventional alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R\/ST2+ regulatory T cells","volume":"193","author":"Matta","year":"2014","journal-title":"J Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674915000135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674915000135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:53:42Z","timestamp":1758790422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674915000135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0091674915000135"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2014.12.1932","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2014.12.1932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}